CLIMARA 100 100 MCG / 24 HOUR
ESTRADIOL (ESTRADIOL HEMIHYDRATE) : 100 MCG / 24 HOUR · DIN 02231510 · BAYER INC
Health Canada status: CANCELLED POST MARKET
What is CLIMARA 100?
CLIMARA 100 100 MCG / 24 HOUR contains ESTRADIOL (ESTRADIOL HEMIHYDRATE) : 100 MCG / 24 HOUR. It is listed in the Health Canada Drug Product Database under DIN 02231510, held by BAYER INC, supplied as PATCH for TRANSDERMAL administration. Health Canada currently lists it as cancelled post market, status dated 26-Jul-2018. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02231510 |
|---|---|
| Brand name | CLIMARA 100 |
| Generic / active ingredient | ESTRADIOL (ESTRADIOL HEMIHYDRATE) : 100 MCG / 24 HOUR |
| Manufacturer | BAYER INC |
| Strength | 100 MCG / 24 HOUR |
| Dosage form | PATCH |
| Route of administration | TRANSDERMAL |
| Schedule | Prescription |
| ATC code | G03CA03 ESTRADIOL |
| AHFS class | 68:16.04 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 26-Jul-2018 |
| Original market date | 1997-12-01 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code G03CA03 ESTRADIOL. 22 of 51 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| CLIMARA 25 | 25 MCG / 24 HOUR | PATCH | BAYER INC | MARKETED | DIN 02247499 |
| CLIMARA 50 | 50 MCG / 24 HOUR | PATCH | BAYER INC | MARKETED | DIN 02231509 |
| CLIMARA 75 | 75 MCG / 24 HOUR | PATCH | BAYER INC | MARKETED | DIN 02247500 |
| DIVIGEL | 0.1 % | GEL | SEARCHLIGHT PHARMA INC | MARKETED | DIN 02424924 |
| DIVIGEL | 0.1 % | GEL | SEARCHLIGHT PHARMA INC | MARKETED | DIN 02424835 |
| DIVIGEL | 0.1 % | GEL | SEARCHLIGHT PHARMA INC | MARKETED | DIN 02424843 |
| ESTRADOT 100 | 100 MCG / 24 HOUR | PATCH | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02244002 |
| ESTRADOT 25 | 25 MCG / 24 HOUR | PATCH | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02245676 |
| ESTRADOT 37.5 | 37.5 MCG / 24 HOUR | PATCH | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02243999 |
| ESTRADOT 50 | 50 MCG / 24 HOUR | PATCH | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02244000 |
Who else supplies ESTRADIOL worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. ESTRADIOL appears in 211 registered pack listings across 14 markets, published on 11 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.